188 related articles for article (PubMed ID: 25455752)
1. Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.
Srour N; Chaparro C; Vandemheen K; Singer LG; Keshavjee S; Aaron SD
J Heart Lung Transplant; 2015 Apr; 34(4):588-93. PubMed ID: 25455752
[TBL] [Abstract][Full Text] [Related]
2. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
3. Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation.
Pritchard J; Thakrar MV; Somayaji R; Surette MG; Rabin HR; Helmersen D; Lien D; Purighalla S; Waddell B; Parkins MD
J Cyst Fibros; 2016 May; 15(3):392-9. PubMed ID: 26657575
[TBL] [Abstract][Full Text] [Related]
4. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
[TBL] [Abstract][Full Text] [Related]
5. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections.
Fothergill JL; Walshaw MJ; Winstanley C
Eur Respir J; 2012 Jul; 40(1):227-38. PubMed ID: 22323572
[TBL] [Abstract][Full Text] [Related]
6. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
7. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Parkins MD; Somayaji R; Waters VJ
Clin Microbiol Rev; 2018 Oct; 31(4):. PubMed ID: 30158299
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
[TBL] [Abstract][Full Text] [Related]
10. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients.
Nunley DR; Grgurich W; Iacono AT; Yousem S; Ohori NP; Keenan RJ; Dauber JH
Chest; 1998 May; 113(5):1235-43. PubMed ID: 9596300
[TBL] [Abstract][Full Text] [Related]
11. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Høiby N; Espersen F; Koch C
Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
[TBL] [Abstract][Full Text] [Related]
12. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
Al-Aloul M; Crawley J; Winstanley C; Hart CA; Ledson MJ; Walshaw MJ
Thorax; 2004 Apr; 59(4):334-6. PubMed ID: 15047956
[TBL] [Abstract][Full Text] [Related]
13. Lung transplantation for non-cystic fibrosis bronchiectasis.
Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis.
Walter S; Gudowius P; Bosshammer J; Römling U; Weissbrodt H; Schürmann W; von der Hardt H; Tümmler B
Thorax; 1997 Apr; 52(4):318-21. PubMed ID: 9196512
[TBL] [Abstract][Full Text] [Related]
15. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
Jones AM; Dodd ME; Doherty CJ; Govan JR; Webb AK
Thorax; 2002 Nov; 57(11):924-5. PubMed ID: 12403871
[TBL] [Abstract][Full Text] [Related]
16. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes of 'Prairie Epidemic Strain'
Somayaji R; Lam JC; Surette MG; Waddell B; Rabin HR; Sibley CD; Purighalla S; Parkins MD
Thorax; 2017 Apr; 72(4):333-339. PubMed ID: 27682327
[TBL] [Abstract][Full Text] [Related]
18. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
[TBL] [Abstract][Full Text] [Related]
19. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat.
Mohan K; Fothergill JL; Storrar J; Ledson MJ; Winstanley C; Walshaw MJ
Thorax; 2008 Sep; 63(9):839-40. PubMed ID: 18728207
[TBL] [Abstract][Full Text] [Related]
20. Nasal polyposis in lung transplant recipients with cystic fibrosis.
Vital D; Holzmann D; Boehler A; Hofer M
J Cyst Fibros; 2013 May; 12(3):266-70. PubMed ID: 22998935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
